Matthias Titeux

7PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Environmental epidemiologyEpidemiological modellingCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2026
Identification of a long-term surviving human mesenchymal stromal cell subpopulation and implications for recessive dystrophic epidermolysis bullosa treatment.

|Dec 05, 2024
Novel variants impairing Sp1 transcription factor binding in the COL7A1 promoter cause mild cases of recessive dystrophic epidermolysis bullosa.

Nathalie Pironon, Artyom Gasparyan, María Joao Yubero

|Aug 19, 2024
Splice modulation strategy applied to deep intronic variants in <i>COL7A1</i> causing recessive dystrophic epidermolysis bullosa.

Nathalie Pironon, Emmanuelle Bourrat, Catherine Prost

|Jul 13, 2024
Citrullinated Histone H3, a Marker for Neutrophil Extracellular Traps, Is Associated with Poor Prognosis in Cutaneous Squamous Cell Carcinoma Developing in Patients with Recessive Dystrophic Epidermolysis Bullosa.

Hélène Ragot, Sonia Gaucher, Mathilde Bonnet des Claustres

|Sep 27, 2019
EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.

S Gaucher, S M Lwin, M Titeux

|Aug 24, 2018
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

Raymond J Cho, Ludmil B Alexandrov, Nicoline Y den Breems

Pageof 2

Frequent Collaborators

5 joint publications

Alain Hovnanian

3 joint publications

Nathalie Pironon

2 joint publications

Su M Lwin

2 joint publications

Emmanuelle Bourrat